Citation Select	Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP Romiplostim or standard of care in patients with immune thrombocytopenia N Engl J Med. 2010 Nov 11;363(20):1889-99
Citation Select	Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S Dose of prophylactic platelet transfusions and prevention of hemorrhage N Engl J Med. 2010 Feb 18;362(7):600-13
Citation Select	Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, Kloczko J, Hassani H, Mayer B, Stone NL, Arning M, Provan D, Jenkins JM Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura N Engl J Med. 2007 Nov 29;357(22):2237-47
Citation Select	Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone N Engl J Med. 2003 Aug 28;349(9):831-6
Citation Select	Godeau B, Chevret S, Varet B, Lefrere F, Zini JM, Bassompierre F, Cheze S, Legouffe E, Hulin C, Grange MJ, Fain O, Bierling P; The French ATIP Study Group Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial Lancet. 2002 Jan 5;359(9300):23-9